Human CYP1B1 Is Regulated by Estradiol via Estrogen Receptor

Cancer Research

Volumn 64, Issue 9, 2004, Pages 3119-3125

  Tsuchiya, Yuki ^a   Nakajima, Miki ^a   Kyo, Satoru ^a   Kanaya, Taro ^a   Inoue, Masaki ^a   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; LUCIFERASE; MESSENGER RNA;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN MCF 7; CHROMATIN; CONTROLLED STUDY; CYP1B1 GENE; ENDOMETRIUM; ENZYME ASSAY; ESTROGEN ACTIVITY; ESTROGEN RELEASE; ESTROGEN RESPONSIVE ELEMENT; GEL; GENE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROXYLATION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MENSTRUAL CYCLE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REPORTER GENE; STAINING; TOXICITY;

ADENOCARCINOMA; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOCHROME P-450 ENZYME SYSTEM; ENDOMETRIUM; ENHANCER ELEMENTS (GENETICS); EPITHELIAL CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MENSTRUAL CYCLE; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS);

EID: 2342516193     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0166     Document Type: Article

References (29)

1. Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacol Rev 1988;40:243-88.
2. Guengerich FP, Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 1991;4:391-407.
3. Sutter TR, Tang YM, Hayes CL, et al. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 1994;269:13092-9.
4. Shimada T, Hayes CL, Yamazaki H, et al. Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res 1996;56:2979-84.
5. Iwanari M, Nakajima M, Kizu R, Hayakawa K, Yokoi T. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences. Arch Toxicol 2002;76:287-98.
6. Hankinson O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 1995;35:307-40.
7. Schmidt JV, Bradfield CA. Ah receptor signaling pathways. Annu Rev Cell Biol 1996;12:55-89.
8. Tsuchiya Y, Nakajima. M, Yokoi T. Critical enhancer region to which AhR/ARNT and Sp1 bind in the human CYP1B1 gene. J Biochem (Tokyo) 2003;133:583-92.
9. Hayes C, Spink D, Spink B, Cao J, Walker N, Sutter T. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 1996;93:9776-81.
10. Spink DC, Spink BC, Cao JQ, et al. Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells. J Steroid Biochem Mol Biol 1997;62:223-32.
11. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT. Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 2003;144:3382-98.
12. Hakkola J, Pasanen M, Pelkonen O, et al. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1BI and CYPIAI by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 1997;18:391-7.
13. Han X, Liehr JG. DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. Carcinogenesis 1994;15:997-1000.
14. Newbold RR, Liehr JG. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 2000;60:235-7.
15. Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA, Zhu BT. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci USA 1995;92:9220-4.
16. Kumar V, Green S, Staub A, Chambon P. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 1986;5:2231-6.
17. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P. Functional domains of the human estrogen receptor. Cell 1987;51:941-51.
18. Kyo S, Takakura M, Kanaya T, et al. Estrogen activates telomerase. Cancer Res 1999;59:5917-21.
19. Tanaka M, Kyo S, Takakura M, et al. Expression of telomerase activity in human endometrium is localized to epithelial glandular cells and regulated in a menstrual phase-dependent manner correlated with cell proliferation. Am J Pathol 1998;153:1985-91.
20. Muskhelishvili L, Thompson PA, Kusewitt DF, Wang C, Kadlubar FF. In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues. J Histochem Cytochem 2001;49:229-36.
21. Igner-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 1993;7:992-8.
22. Ignar-Trowbridge DM, Pimentel M, Teng CT, Korach KS, McLachlan JA. Cross talk between peptide growth factor and estrogen receptor signaling systems. Environ Health Perspect 1995;103:35-8.
23. Spink DC, Katz BH, Hussain MM, Pentecost BT, Cao Z, Spink BC. Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis 2003;24:1941-50.
24. Petz LN, Nardulli AM. Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. Mol Endocrinol 2000;14:972-85.
25. Saville B, Wormke M, Wang F, et al. Ligand-, cell-, and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 2000;275:5379-87.
26. Wo, Y-YP, Stewart J, Greenlee WF. Functional analysis of the promoter for the human CYP1B1 gene. J Biol Chem 1997;272:26702-7.
27. Alsbach GP, Franck ER, Poortman J, Thijssen JH. Subcellular distribution of estradiol and estrone in human endometrium and myometrium during the menstrual cycle. Contraception 1983;27:409-21.
28. Lemon HM, Heidel JW, Rodriguez-Sierra JF. Increased catechol estrogen metabolism as a risk factor for nonfamilial breast cancer. Cancer 1992;69:457-65.
29. Levenson AS, Jordan VC. Selective oestrogen receptor modulation: molecular pharmacology for the millennium. Eur J Cancer 1999;35:1974-85.